Genmab — Maj 2021

[kkjoel]

EL, not often we see numbers in format in here.. is that for Genmab or the Galapagos link just before?

[kkjoel]

..in that format..

[deleted-user]

Det ligner en overskudsgrad på 25 % og en omsætning omkring 30 mia

[deleted-user]

i 2025

[E_L]

oh sorry, Genmab. we should expect to see a new price target as i guess, last i had was 2800 in Feb

[E_L]

*as well

[kkjoel]

Tnx. I have the same target from feb. Maybe someone in here are are smart enough to translate these numbers into other, more easily understandable measures?

[kkjoel]

the likes of: he's seeing x DKK/$ profit for 22.. stuff like that.

[E_L]

LLi just made an attempt, with another profit margin that would be a different revenue number offcourse.

[deleted-user]

Is it fair to assume the marginal profit in 2025 is closer to 40 % than 20 % due to the high income from Dara which contribute with maybe 90 % profit?

[deleted-user]

I guess a fair benchmark is 20-25 % for revenue related to own products

[E_L]

i find it very hard to predict, your Dara comment is fair, however, IF the epco and Biontech programs are successfull, we will probably still see massive investmens in 2024-2025 in additional Ph3 trials, thereby still cutting margins in those years?

[deleted-user]

EPS 1.96 2025 is to low. And more likely to be around 2.5-3.0... or I hope

[E_L]

hope is a great investment strategy

[deleted-user]

If the margin is around 40 % it will reflect running cost of 18 bDKK - think about that number versus 2021

[E_L]

sounds crazy doesn't it...

[deleted-user]

I know the numbers contains more uncertainty than safety

[Helge_LarsenPI-redaktør]

Utroligt hvad en dårlig jobrapport kan gøre ved røde aktiekurser.

[Bulder]

Man tør slet ikke tænke på, hvis der var kommer 1 mio i arbejde. Så var kurserne da raslet ned.

[E_L]

i think the lesson from this should be: it is best not to work Have a good weekend